- Home
- ELVN vs PGY Comparison
ELVN vs PGY Comparison
Compare ELVN & PGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELVN | PGY |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.8B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELVN | PGY |
|---|---|---|
| Price | $17.00 | $22.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $41.20 | $39.86 |
| AVG Volume (30 Days) | 632.8K | ★ 2.8M |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,245,946,000.00 |
| Revenue This Year | N/A | $28.75 |
| Revenue Next Year | N/A | $17.23 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 28.33 |
| 52 Week Low | $13.30 | $8.27 |
| 52 Week High | $25.37 | $44.99 |
Technical Indicators
Market Signals| Indicator | ELVN | PGY |
|---|---|---|
| Relative Strength Index (RSI) | 33.61 | 41.02 |
| Support Level | $17.31 | $22.61 |
| Resistance Level | $20.47 | $25.64 |
| Average True Range (ATR) | 1.39 | 1.36 |
| MACD | -0.41 | 0.24 |
| Stochastic Oscillator | 6.66 | 28.02 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About PGY Pagaya Technologies Ltd.
Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.